| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/12/2000 | EP0969869A2 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders |
| 01/12/2000 | EP0969868A2 Methods and kits for treating and diagnosing leiomyomas |
| 01/12/2000 | EP0969866A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 01/12/2000 | EP0969841A1 Use of carboxylic acid derivatives for treating cancer |
| 01/12/2000 | EP0969829A1 Synthetic techniques and intermediates for polyhydroxy, dienyllactones and mimics thereof |
| 01/12/2000 | EP0969828A1 Butyrate prodrugs derived from lactic acid |
| 01/12/2000 | EP0969822A2 Compositions and methods for restoring a normal pattern of imprinting to cells |
| 01/12/2000 | EP0969720A2 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 01/12/2000 | EP0714390B1 Indole derivatives as 5-alpha-reductase-1-inhibitors |
| 01/12/2000 | EP0639079B1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 01/12/2000 | CN1241192A Pro-drugs and counterparts of camptothecin, their application as medicines |
| 01/12/2000 | CN1241191A Counterparts of camptothecin, their application as medicine and pharmaceutical compositions contg. them |
| 01/12/2000 | CN1241177A Substed. 4-biphenyl-4-hydroxybutyric acid derivs. as matrix metalloprotease inhibitors |
| 01/12/2000 | CN1240659A Anticancer and antalgesic oral liquid |
| 01/12/2000 | CN1048296C Process for preparation of 9-amino camptothecin |
| 01/12/2000 | CN1048241C Vitamin D analogues, their preparing process, pharmaceutical composition contg. same and use thereof |
| 01/11/2000 | US6013828 Processes and intermediates useful to make antifolates |
| 01/11/2000 | US6013814 Vitamin D analogues |
| 01/11/2000 | US6013807 Amidation to produce compound having low toxicity and antitumor activity |
| 01/11/2000 | US6013792 Matrix metalloprotease inhibitors |
| 01/11/2000 | US6013786 Nucleotide sequences used as inhibitors of the oncogenic action of the encoded protein; antitumor agents |
| 01/11/2000 | US6013781 Semaphorin gene family |
| 01/11/2000 | US6013765 Cell surface peptides that can be used as antitumor agents |
| 01/11/2000 | US6013646 Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| 01/11/2000 | US6013639 G cap-stabilized oligonucleotides |
| 01/11/2000 | US6013627 Organic compounds |
| 01/11/2000 | US6013626 To inhibit the proliferation of mammalian cells; antitumor agents |
| 01/11/2000 | US6013624 Administering an amount of scatter factor effective to induce the proliferation and migration of endothelial cells in the subject; wound healing |
| 01/11/2000 | US6013487 Chimeric RNA molecules generated by trans-splicing |
| 01/11/2000 | US6013476 DNA encoding tumor necrosis related receptor TR7 |
| 01/11/2000 | US6013473 Nucleic acid sequence encoding a deoxyribonucleic acid repair enzyme; for treatment, prevention, and diagnosing cancer; antitumor/anticarcinogenic agents |
| 01/11/2000 | US6013464 Human PAK65 |
| 01/11/2000 | US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/11/2000 | US6013453 Libraries of dna sequences encoding zinc finger binding motifs for display on a viral particle, together with methods of designing zinc finger binding polypeptides for binding to a target sequence |
| 01/11/2000 | US6013450 CAF1-related protein |
| 01/11/2000 | US6013278 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 01/11/2000 | US6013258 Immunogenic peptides from the HPV E7 protein |
| 01/11/2000 | US6013257 Neurotactin and uses therefor |
| 01/11/2000 | US6013240 Nucleic acid containing composition, preparation and uses of same |
| 01/11/2000 | US6012375 Aircraft infrared guided defense missile system |
| 01/11/2000 | CA2180754C Heteroaryl-substituted deoxy glycero-phosphoethanolamines |
| 01/07/2000 | CA2276791A1 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 01/06/2000 | WO2000000825A2 Detection and modulation of cellular immunity to immune privileged antigens |
| 01/06/2000 | WO2000000644A1 Uses of dna-pk |
| 01/06/2000 | WO2000000610A2 Human signal peptide-containing proteins |
| 01/06/2000 | WO2000000609A2 Molecules associated with apoptosis |
| 01/06/2000 | WO2000000599A2 Composition for the induction of apoptosis in target cells |
| 01/06/2000 | WO2000000596A1 3'-exonuclease, production and use thereof |
| 01/06/2000 | WO2000000594A2 Human transferases |
| 01/06/2000 | WO2000000587A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | WO2000000514A2 Synthetic spiroketal pyranes as potent anti-cancer agents |
| 01/06/2000 | WO2000000510A2 Growth factor modulators |
| 01/06/2000 | WO2000000509A2 Peptides for inhibiting hpv e7 proteins |
| 01/06/2000 | WO2000000483A2 Tubulin binding compounds (cobra) |
| 01/06/2000 | WO2000000473A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 01/06/2000 | WO2000000469A2 Alkyl ketones as potent anti-cancer agents |
| 01/06/2000 | WO2000000465A1 Hydrazine derivatives |
| 01/06/2000 | WO2000000462A1 Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same |
| 01/06/2000 | WO2000000223A2 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS |
| 01/06/2000 | WO2000000216A2 Use of poxviruses as enhancer of specific immunity |
| 01/06/2000 | WO2000000214A2 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 01/06/2000 | WO2000000207A1 Treatment of hyperproliferative disorders |
| 01/06/2000 | WO2000000189A1 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa |
| 01/06/2000 | WO2000000157A2 Use of tempo and tempo derivatives for inducing cell death |
| 01/06/2000 | WO1999058565A8 Cystatin-related protein |
| 01/06/2000 | WO1999058505A3 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| 01/06/2000 | WO1999057270A3 Human receptor molecules |
| 01/06/2000 | WO1999055855A3 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 01/06/2000 | WO1999051185A3 Human galactosyl transferases |
| 01/06/2000 | WO1999044629A3 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 01/06/2000 | WO1999043829A3 Cell cycle related proteins |
| 01/06/2000 | WO1999017759A3 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 01/06/2000 | WO1999000137A3 Induction of an activated myeloid dendritic cell phenotype |
| 01/06/2000 | WO1998001460A8 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/06/2000 | CA2336382A1 Methods and agents for the detection and modulation of cellular immunity to immune privileged antigens |
| 01/06/2000 | CA2336309A1 Tubulin binding compounds (cobra) |
| 01/06/2000 | CA2336306A1 Indium photosensitizers for pdt |
| 01/06/2000 | CA2336294A1 Synthetic spiroketal pyranes as potent anti-cancer agents |
| 01/06/2000 | CA2336108A1 Alkyl ketones as potent anti-cancer agents |
| 01/06/2000 | CA2335986A1 Use of tempo and tempo derivatives for inducing cell death |
| 01/06/2000 | CA2335921A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 01/06/2000 | CA2335516A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | CA2335508A1 Use of poxviruses as enhancer of specific immunity |
| 01/06/2000 | CA2335245A1 Hydrazine derivatives |
| 01/06/2000 | CA2334046A1 3'-exonuclease, its preparation and use |
| 01/06/2000 | CA2332379A1 Molecules associated with apoptosis |
| 01/06/2000 | CA2332127A1 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 01/06/2000 | CA2331399A1 Thienopyridine compounds, their production and use |
| 01/06/2000 | CA2331386A1 Human signal peptide-containing proteins |
| 01/06/2000 | CA2330565A1 Growth factor modulators |
| 01/06/2000 | CA2330525A1 Human transferases |
| 01/05/2000 | EP0969091A2 Leptin receptor gene-related protein |
| 01/05/2000 | EP0969013A1 Peptides for inhibiting HPV E7 proteins |
| 01/05/2000 | EP0968432A1 Growth factor-dependent diseases |
| 01/05/2000 | EP0968299A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors |
| 01/05/2000 | EP0968290A1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 01/05/2000 | EP0968286A1 Growth factor receptor binding protein |
| 01/05/2000 | EP0968281A2 An oncolytic/immunogenic complementary-adenoviral vector system |
| 01/05/2000 | EP0968213A1 Alkynyl-substituted camptothecins and process for their preparation |